Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2023-05-24 00:00:00 ET · period of report 2023-05-22 · accession 0001209191-23-031910 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-24 | 2023-05-22 | HRTX | Collard Craig A | CEO, Dir | F - Tax | $1.45 | -691 | 37.2K | -2% | -$1,002 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-22 | F | D | 691 | $1.45 | 37,188 | D | — | — | (F1) Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to the quarterly vesting of shares from the restricted stock grant made on February 22, 2023. |